Rezultati - Matthias Pfisterer
- Showing 1 - 20 results of 36
- Go to Next Page
-
1
-
2
Raised cardiac troponins od Peter Ammann, Matthias Pfisterer, Thomas Fehr, Hans Rickli
Izdano 2004Editorial -
3
-
4
-
5
-
6
-
7
Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial od Thilo Burkard, Christoph Kaiser, Hans‐Peter Brunner‐La Rocca, Stefan Osswald, Matthias Pfisterer, Raban Jeger
Izdano 2011Artigo -
8
Prevention of Supraventricular Tachyarrhythmias After Open Heart Operation by Low-Dose Sotalol: A Prospective, Double-Blind, Randomized, Placebo-Controlled Study od Matthias Pfisterer, Uta C.D Klöter-Weber, Maurus Huber, Stefan Osswald, Peter Buser, K. Skarvan, P Stulz
Izdano 1997Artigo -
9
Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coron... od Miodrag Filipovic, Raban Jeger, C Probst, Thierry Girard, Matthias Pfisterer, Lorenz Gürke, K. Skarvan, Manfred D. Seeberger
Izdano 2003Artigo -
10
-
11
-
12
Prognostic Value of Abnormal Vasoreactivity of Epicardial Coronary Arteries to Sympathetic Stimulation in Patients With Normal Coronary Angiograms od Thomas H. Schindler, Burkhard Hornig, Peter Buser, Manfred Olschewski, Nobuhisa Magosaki, Matthias Pfisterer, Egbert Nitzsche, U. Solzbach, H. Just
Izdano 2003Artigo -
13
Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction od Sandra Sanders‐van Wijk, Vanessa van Empel, Nasser Davarzani, Micha T. Maeder, Rolf Handschin, Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca
Izdano 2015Artigo -
14
Heart failure with mid‐range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congesti... od Peter Rickenbacher, Beat A. Kaufmann, Micha T. Maeder, Alain Bernheim, Kaatje Goetschalckx, Otmar Pfister, Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca
Izdano 2017Artigo -
15
Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET od Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca, Peter Rickenbacher, Patrick Hunziker, Christian Mueller, F. Nietlispach, Gregor Leibundgut, Franziska Bader, Christoph Kaiser
Izdano 2008Artigo -
16
Frequency and Predictors of Hyperkalemia in Patients ≥60 Years of Age With Heart Failure Undergoing Intense Medical Therapy od Stefano Muzzarelli, Micha T. Maeder, Stefan Toggweiler, Hans Rickli, Fabian Nietlispach, Barbara Julius, Thilo Burkard, Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca
Izdano 2011Artigo -
17
Drug-Eluting Stents Compared with Bare Metal Stents Improve Late Outcome after Saphenous Vein Graft but Not after Large Native Vessel Interventions od Raban Jeger, Stefan Schneiter, Christoph Kaiser, Piero O. Bonetti, Hans‐Peter Brunner‐La Rocca, Michael Handke, Stefan Osswald, Peter Buser, Matthias Pfisterer
Izdano 2008Artigo -
18
-
19
Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME‐CHF) randomized... od Marjolein Huijts, Robert J. van Oostenbrugge, Annelien Duits, Thilo Burkard, Stefano Muzzarelli, Micha T. Maeder, Ruth Schindler, Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca
Izdano 2013Artigo -
20
N‐terminal pro brain natriuretic peptide‐guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard Me... od Micha T. Maeder, Peter Rickenbacher, Hans Rickli, Heidi Abbühl, Marc Gutmann, Paul Erné, André Vuilliomenet, Martin G. Peter, Matthias Pfisterer, Hans‐Peter Brunner‐La Rocca
Izdano 2013Artigo
Iskalna orodja:
Sorodne teme
Medicine
Internal medicine
Cardiology
Myocardial infarction
Heart failure
Confidence interval
Coronary artery disease
Ejection fraction
Surgery
Randomized controlled trial
Hazard ratio
Natriuretic peptide
Odds ratio
Percutaneous coronary intervention
Stent
Drug-eluting stent
Restenosis
Anesthesia
Artery
Bare metal
Blood pressure
Nursing
Revascularization
Asymptomatic
Atrial fibrillation
Bare-metal stent
Coronary arteries
Creatinine
Heart failure with preserved ejection fraction
Heart rate